Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells

MLA

Julieta Martino, et al. “Inhibitors of Rho Kinases (ROCK) Induce Multiple Mitotic Defects and Synthetic Lethality in BRCA2-Deficient Cells.” ELife, vol. 12, Apr. 2023. EBSCOhost, https://doi.org/10.7554/eLife.80254.

APA

Julieta Martino, Sebastián Omar Siri, Nicolás Luis Calzetta, Natalia Soledad Paviolo, Cintia Garro, Maria F Pansa, Sofía Carbajosa, Aaron C Brown, José Luis Bocco, Israel Gloger, Gerard Drewes, Kevin P Madauss, Gastón Soria, & Vanesa Gottifredi. (2023). Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells. ELife, 12. https://doi.org/10.7554/eLife.80254

Chicago

Julieta Martino, Sebastián Omar Siri, Nicolás Luis Calzetta, Natalia Soledad Paviolo, Cintia Garro, Maria F Pansa, Sofía Carbajosa, et al. 2023. “Inhibitors of Rho Kinases (ROCK) Induce Multiple Mitotic Defects and Synthetic Lethality in BRCA2-Deficient Cells.” ELife 12 (April). doi:10.7554/eLife.80254.